Clobetasol

DRUG10 trials

Conditions

Carcinoma, Non-Small-Cell LungDermatitis, ContactDermatitis, OccupationalDrug Rash With Eosinophilia and Systemic SymptomsGraft vs Host DiseaseOral Lichen PlanusOral ManifestationsPsoriasis

Phase 1

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

WithdrawnNCT02680717

Medical College of WisconsinScleroderma

Start: 2016-03-31End: 2017-05-31Updated: 2018-07-18

Phase 2

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

CompletedNCT00715975

Azidus BrasilPsoriasis

Start: 2008-07-31End: 2010-08-31Target: 140Updated: 2010-09-02

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

RecruitingNCT06120140

Janssen Research & Development, LLCCarcinoma, Non-Small-Cell Lung

Start: 2024-02-16End: 2032-01-31Target: 300Updated: 2026-03-13

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

RecruitingNCT06742333

Centre Hospitalier Universitaire de NicePsoriasis

Start: 2025-07-22End: 2029-01-01Target: 40Updated: 2025-11-25

A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study

CompletedNCT06752343

Wroclaw Medical UniversityOral Lichen Planus

Start: 2023-06-01End: 2024-10-01Updated: 2024-12-30

Phase 3

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

CompletedNCT01699412

Grupo de Estudos Multicentricos em Onco-HematologiaGraft vs Host Disease, Oral Manifestations

Start: 2008-08-31End: 2012-08-31Updated: 2012-10-03

Phase 4

Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation

NCT00779792

Odense University HospitalDermatitis, Contact, Dermatitis, Occupational

Start: 2008-09-30End: 2008-11-30Updated: 2008-10-24

Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized trial

Active, not recruitingCTIS2022-501179-23-00

Centre Hospitalier Universitaire De Nantesatopic dermatitis

Start: 2023-03-08Target: 256Updated: 2025-07-11

Unknown Phase

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

TerminatedNCT00470392

VA Office of Research and DevelopmentPsoriasis

Start: 2007-05-31End: 2012-07-31Updated: 2016-10-05

Comparison Between Corticosteroid and Topical Steroids in the DRESS

NCT01987076

Assistance Publique - Hôpitaux de ParisDrug Rash With Eosinophilia and Systemic Symptoms

Start: 2013-10-31End: 2016-10-31Target: 112Updated: 2015-07-30

Related Papers

Dupilumab step-down strategy to maintain remission in adult and adolescent patients with atopic dermatitis: study protocol for a non-inferiority randomized trial (MADULO).

2025-12-05

Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial.

2025-09-091 citations

Dermatologic prophylaxis and impact on patient-reported outcomes in first-line <i>EGFR</i> -mutant advanced NSCLC treated with amivantamab plus lazertinib: Results from the phase 2 COCOON trial.

Journal of Clinical Oncology2025-05-281 citations